What this episode covers
A patient has taken the same clonazepam dose responsibly for more than a decade, and the medication has probably helped him. But sleep apnea, fatigue, memory concerns, a fall, alcohol exposure, and better treatment of his underlying anxiety have changed the clinical picture. This case excerpt follows how I decide that a taper should be attempted and how I begin that conversation without making the patient feel accused.
How do you recommend a benzodiazepine taper when the patient has used the medication responsibly and still believes it is helping?
- Identify what has changed: duration alone is not enough reason to disrupt a stable regimen.
- Explain the recommendation without blame: acknowledge both the patient’s responsible use and the medication’s prior benefit.
- Begin without forcing the endpoint: the first conversation does not have to include a dose reduction or a complete taper schedule.
Quick Practical Takeaways
- A stable dose does not mean stable risk. The same prescription may look different as the patient ages or develops new cognitive, respiratory, balance, driving, or substance-related risks.
- Check your own reasoning before recommending a taper. Ask whether you are responding to a meaningful clinical change or mainly to discomfort with long-term benzodiazepine use.
- Responsible use still matters. It should shape the pace, tone, and degree of collaboration even when it does not eliminate the need to reconsider the dose.
- Physical dependence is not the same as addiction. After years of regular use, preventing an abrupt interruption remains part of safe treatment.
- Name the clinical reasons for change. Patients deserve a more specific explanation than simply hearing that the prescriber is no longer comfortable.
- Separate the decision to try from the final destination. You can recommend an attempt to reduce risk without predetermining the pace or insisting that the endpoint must be zero.
- The first conversation can be part of the intervention. Allowing time to process the recommendation may be more productive than making an immediate reduction.
Listen Now
Prefer to listen on the go? This podcast is available for free on Spotify, Apple Podcasts, and wherever you get your podcasts—just search Collaborative Psychiatry QuickTakes.
Use This in Clinic
Before deciding whether to continue, modify, or taper a benzodiazepine, use this two-page tool to clarify what the medication is doing, what has changed, what needs stabilization, and what the next treatment goal should be.
Free clinical tool
Benzodiazepine Prescription Review
A structured checklist for inherited prescriptions, transfer of care, and periodic reassessment of ongoing treatment.
- Clarify the original indication, actual use, and meaningful functional benefit
- Review dependence, prior change attempts, other sedatives, and emerging risks
- Choose among continuation, stabilization, regimen improvement, risk reduction, or tapering
Selected from the complete Benzodiazepines in the Grey Zone Clinical Toolkit.
Continue the case
This QuickTake stops after the first conversation. In the full case, follow what happens through the initial reduction, periods when the taper needs to pause, formulation limitations, a later switch to diazepam, the lower-dose phase, and the decision about where the taper should ultimately end.
Benzodiazepines in the Grey Zone also includes the Core Framework, additional case walkthroughs, and an 11-resource Clinical Toolkit with practical prescribing tools and patient handouts.